Lamisil Once

Terbinafine, the active ingredient in Lamisil Once, is an allylamine antifungal presented as a topical cream for skin use. It treats dermatophyte infections such as athlete's foot, ringworm and jock itch in patients with superficial fungal skin conditions.

GNH USA supplies Lamisil Once as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamisil Once is an allylamine antifungal indicated for dermatophyte skin infections.

- Tinea pedis (athlete's foot): clears fungal infection and relieves itching. - Tinea corporis (ringworm): resolves erythematous lesions and prevents spread. - Tinea cruris (jock itch): eliminates fungal growth and reduces discomfort.

Topical terbinafine may cause local reactions, most of which are mild and transient.

Common Side Effects: - Burning sensation at the application site. - Itching or pruritus. - Redness or erythema. - Dryness or flaking of the skin. - Stinging feeling. - Mild irritation.

Serious or Rare Side Effects: - Allergic contact dermatitis. - Severe skin rash or bullous eruption. - Swelling of the face, lips or tongue. - Systemic hypersensitivity reactions. - Unexplained fever or malaise. - Rare systemic toxicity if absorbed in large amounts.

Before using Lamisil Once, consider the following safety measures.

- Apply to intact skin only: avoid broken or inflamed areas. - Avoid contact with eyes, mouth and mucous membranes. - Do not use under occlusive dressings unless directed by a clinician. - Keep out of reach of children and pets. - Discontinue use if a severe allergic reaction occurs. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Terbinafine topical may interact with other skin products, affecting absorption or irritation risk.

Major Interactions (Avoid): - Concurrent use with other topical antifungals containing alcohol may increase irritation. - Combining with potent corticosteroid creams can mask infection signs.

Moderate Interactions (Monitor Closely): - Use with occlusive bandages may raise systemic absorption. - Application together with other irritant cosmetics or lotions. - Co‑application with phototoxic agents such as certain sunscreens. - Use alongside systemic terbinafine may increase overall exposure.